Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis

A Ceribelli, N Isailovic, M De Santis, E Generali… - Journal of …, 2018 - Elsevier
Objective To describe a new immunoprecipitation pattern identified in Italian patients
affected by systemic sclerosis (SSc), corresponding to the pyruvate dehydrogenase antigen …

[PDF][PDF] Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase

D Ding, G Xuan, Y Hu, J Yu, Y Liu… - Hepatology …, 2022 - Wiley Online Library
The diagnosis of primary biliary cholangitis (PBC) in patients with seropositive anti‐
mitochondrial antibody (AMA) but normal alkaline phosphatase (ALP) depends on a liver …

Evidence for the association between IgG‐antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis

L Tang, R Zhong, X He, W Wang, J Liu… - Journal of …, 2017 - Wiley Online Library
Abstract Background and Aim Antimitochondrial antibody (AMA) is considered the
serological hallmark of primary biliary cholangitis (PBC), while data regarding the profile of …

The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis

EMM Kuiper, BE Hansen, W Lesterhuis… - Clinics and research in …, 2011 - Elsevier
Background and aims Ursodeoxycholic acid (UDCA) has an established effect on liver
biochemistries in primary biliary cirrhosis (PBC). Few studies have evaluated long-term …

[HTML][HTML] Role of autoimmunity in primary biliary cirrhosis

TY Shi, FC Zhang - World Journal of Gastroenterology: WJG, 2012 - ncbi.nlm.nih.gov
Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by the
presence of serum autoantibodies and chronic nonsuppurative destructive cholangitis. The …

[HTML][HTML] 原发性胆汁性肝硬化发病机制的研究进展

黄颖秋 - 世界华人消化杂志, 2012 - wjgnet.com
原发性胆汁性肝硬化(primary biliary cirrhosis, PBC) 是一种慢性进行性胆汁淤积性自身免疫性
肝病, 以肝内小胆管破坏及血清高特异性抗线粒体抗体(antimitochondrial antibodies, AMAs) …

熊去氧胆酸治疗乙型肝炎肝硬化的临床疗效

王晓艳, 沈守荣, 李楠, 李予 - 中南大学学报: 医学版, 2010 - cqvip.com
目的: 观察熊去氧胆酸在乙型肝炎肝硬化治疗中的临床疗效. 方法: 84 例乙型肝炎肝硬化患者
随机分为治疗组和对照组, 分别给予熊去氧胆酸联合还原型谷胱甘肽和茵栀黄联合还原型谷胱甘 …

[HTML][HTML] Anti-mitochondrial antibody titers decrease over time in primary biliary cholangitis patients with ursodeoxycholic acid therapeutic response: a cohort study …

ML Chang, WT Chen, TM Chan, CY Lin… - Frontiers in …, 2022 - frontiersin.org
Background How anti-mitochondrial antibody (AMA) and liver biochemistry levels change in
primary biliary cholangitis (PBC) patients treated with ursodeoxycholic acid (UDCA) remains …

Effects of dietary brown rice on the growth performance, systemic oxidative status, and splenic inflammatory responses of broiler chickens under chronic heat stress

F Nanto-Hara, H Ohtsu, M Yamazaki… - The Journal of Poultry …, 2021 - jstage.jst.go.jp
The aim of this study was to evaluate the effects of dietary brown rice on the growth
performance, systemic oxidative status, and splenic inflammatory responses of broiler …

原发性胆汁性肝硬化的免疫发病机制研究进展

李晓姝, 曾辉, 王宪波 - 临床肝胆病杂志, 2015 - cqvip.com
原发性胆汁性肝硬化(PBC) 是以慢性进行性胆汁淤积为主要特征的自身免疫性肝病,
有发展为肝硬化的倾向, 其发病机制复杂, 病因尚不明确. 归纳了近年来PBC …